Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer

Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, owing to its aggressive nature and poor prognosis. The role of folate receptors, particularly folate receptor 1 (FOLR1) and folate receptor 2 (FOLR2), in cancer has been increasingly recognized due to their overexpres...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e61032
Main Authors: Anitha, S, Ramasamy, Raveendran, Nachiappa Ganesh, Rajesh, Dubashi, Biswajit
Format: Article
Language:English
Subjects:
Antibodies
Antigens
Cancer
Chemotherapy
Dehydrogenases
Demographics
Gastric cancer
Genetics
Metastasis
Oncology
Patients
Proteins
Statistical analysis
Survival analysis
Therapeutics
Thermal cycling
Treatment resistance
Vitamin B
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c300t-24d08aca0d480cbe25e22dfa1a3440206d28a6b086a35045f5cae6a2650db99a3
container_end_page
container_issue 5
container_start_page e61032
container_title Curēus (Palo Alto, CA)
container_volume 16
creator Anitha, S
Ramasamy, Raveendran
Nachiappa Ganesh, Rajesh
Dubashi, Biswajit
description Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, owing to its aggressive nature and poor prognosis. The role of folate receptors, particularly folate receptor 1 (FOLR1) and folate receptor 2 (FOLR2), in cancer has been increasingly recognized due to their overexpression in various malignancies including gastric cancer, and its potential implications in cancer progression, treatment resistance and as therapeutic targets. To evaluate the expression patterns of FOLR1 and FOLR2 in GC patients' tissue and blood specimens and to correlate these patterns with clinicopathological variables. A total of 58 gastric cancer patients were enrolled at the Regional Cancer Centre (RCC) from March 2017 to March 2020. Immunohistochemical analysis was performed to examine the expression of FOLR1 and FOLR2 in formalin-fixed paraffin-embedded (FFPE) tissue samples. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to analyze FOLR1 and FOLR2 expression in blood samples. Statistical analyses were conducted using chi-square tests, independent T-tests, and Kaplan-Meier survival analysis. FOLR1 and FOLR2 were overexpressed in 82.76% and 70.69% of gastric cancer tissues, respectively. High expression levels of FOLR1 were significantly associated with the diffuse type of gastric cancer (p
doi_str_mv 10.7759/cureus.61032
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11194536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3073874058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-24d08aca0d480cbe25e22dfa1a3440206d28a6b086a35045f5cae6a2650db99a3</originalsourceid><addsrcrecordid>eNpdkctv1DAQxiMEolXpjTOyxIUDW8Z2Hs4JoajbIq1UVPE4WhNn0nWVtYPtVHDhb2-yW6rCaUaa33zz-LLsNYezqirqD2YKNMWzkoMUz7JjwUu1Ulzlz5_kR9lpjLcAwKESUMHL7Eiqmhd1WRxnf85_jYFitN4x37O0Jbb2AyZi12RoTD6wL8Ensi6y9dXmmjN03T4TzDrW-BBoxpf2HzZtWTNYZ40fMW394G-swYF9x2CxHSguEy4wpmANa9AZCq-yFz0OkU4f4kn2bX3-tblcba4uPjefNisjAdJK5B0oNAhdrsC0JAoSouuRo8xzEFB2QmHZgipRFpAXfWGQShRlAV1b1yhPso8H3XFqd9QZcingoMdgdxh-a49W_1txdqtv_J3mnNd5IctZ4d2DQvA_J4pJ72w0NAzoyE9Ry-W5IEShZvTtf-itn4Kb71soqaoc9tT7A2WCjzFQ_7gNB72Yqw_m6r25M_7m6QWP8F8r5T2tSaG2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3073874058</pqid></control><display><type>article</type><title>Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer</title><source>Open Access: PubMed Central</source><source>ProQuest Publicly Available Content database</source><creator>Anitha, S ; Ramasamy, Raveendran ; Nachiappa Ganesh, Rajesh ; Dubashi, Biswajit</creator><creatorcontrib>Anitha, S ; Ramasamy, Raveendran ; Nachiappa Ganesh, Rajesh ; Dubashi, Biswajit</creatorcontrib><description>Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, owing to its aggressive nature and poor prognosis. The role of folate receptors, particularly folate receptor 1 (FOLR1) and folate receptor 2 (FOLR2), in cancer has been increasingly recognized due to their overexpression in various malignancies including gastric cancer, and its potential implications in cancer progression, treatment resistance and as therapeutic targets. To evaluate the expression patterns of FOLR1 and FOLR2 in GC patients' tissue and blood specimens and to correlate these patterns with clinicopathological variables. A total of 58 gastric cancer patients were enrolled at the Regional Cancer Centre (RCC) from March 2017 to March 2020. Immunohistochemical analysis was performed to examine the expression of FOLR1 and FOLR2 in formalin-fixed paraffin-embedded (FFPE) tissue samples. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to analyze FOLR1 and FOLR2 expression in blood samples. Statistical analyses were conducted using chi-square tests, independent T-tests, and Kaplan-Meier survival analysis. FOLR1 and FOLR2 were overexpressed in 82.76% and 70.69% of gastric cancer tissues, respectively. High expression levels of FOLR1 were significantly associated with the diffuse type of gastric cancer (p&lt;0.005). qRT-PCR showed significant overexpression of FOLR1 in gastric cancer blood samples compared to control samples, with a median fold change of approximately 14.18 times. Conversely, FOLR2 was significantly underexpressed in gastric cancer samples, with a fold change of 0.30. However, no significant correlation was found between FOLR2 expression and the clinicopathological features. The overall survival analysis did not show a significant difference in survival rates based on the expression levels of FOLR1 and FOLR2. This study highlights the differential expression patterns of FOLR1 and FOLR2 in gastric cancer and underscores the complexity of their roles in cancer biology. While FOLR1 shows potential as a biomarker for gastric cancer due to its overexpression, further studies are needed to fully elucidate the therapeutic and prognostic implications of folate receptors in gastric cancer.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.61032</identifier><identifier>PMID: 38915965</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antibodies ; Antigens ; Cancer ; Chemotherapy ; Dehydrogenases ; Demographics ; Gastric cancer ; Genetics ; Metastasis ; Oncology ; Patients ; Proteins ; Statistical analysis ; Survival analysis ; Therapeutics ; Thermal cycling ; Treatment resistance ; Vitamin B</subject><ispartof>Curēus (Palo Alto, CA), 2024-05, Vol.16 (5), p.e61032</ispartof><rights>Copyright © 2024, Anitha et al.</rights><rights>Copyright © 2024, Anitha et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024, Anitha et al. 2024 Anitha et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-24d08aca0d480cbe25e22dfa1a3440206d28a6b086a35045f5cae6a2650db99a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3073874058/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3073874058?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38915965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anitha, S</creatorcontrib><creatorcontrib>Ramasamy, Raveendran</creatorcontrib><creatorcontrib>Nachiappa Ganesh, Rajesh</creatorcontrib><creatorcontrib>Dubashi, Biswajit</creatorcontrib><title>Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, owing to its aggressive nature and poor prognosis. The role of folate receptors, particularly folate receptor 1 (FOLR1) and folate receptor 2 (FOLR2), in cancer has been increasingly recognized due to their overexpression in various malignancies including gastric cancer, and its potential implications in cancer progression, treatment resistance and as therapeutic targets. To evaluate the expression patterns of FOLR1 and FOLR2 in GC patients' tissue and blood specimens and to correlate these patterns with clinicopathological variables. A total of 58 gastric cancer patients were enrolled at the Regional Cancer Centre (RCC) from March 2017 to March 2020. Immunohistochemical analysis was performed to examine the expression of FOLR1 and FOLR2 in formalin-fixed paraffin-embedded (FFPE) tissue samples. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to analyze FOLR1 and FOLR2 expression in blood samples. Statistical analyses were conducted using chi-square tests, independent T-tests, and Kaplan-Meier survival analysis. FOLR1 and FOLR2 were overexpressed in 82.76% and 70.69% of gastric cancer tissues, respectively. High expression levels of FOLR1 were significantly associated with the diffuse type of gastric cancer (p&lt;0.005). qRT-PCR showed significant overexpression of FOLR1 in gastric cancer blood samples compared to control samples, with a median fold change of approximately 14.18 times. Conversely, FOLR2 was significantly underexpressed in gastric cancer samples, with a fold change of 0.30. However, no significant correlation was found between FOLR2 expression and the clinicopathological features. The overall survival analysis did not show a significant difference in survival rates based on the expression levels of FOLR1 and FOLR2. This study highlights the differential expression patterns of FOLR1 and FOLR2 in gastric cancer and underscores the complexity of their roles in cancer biology. While FOLR1 shows potential as a biomarker for gastric cancer due to its overexpression, further studies are needed to fully elucidate the therapeutic and prognostic implications of folate receptors in gastric cancer.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Dehydrogenases</subject><subject>Demographics</subject><subject>Gastric cancer</subject><subject>Genetics</subject><subject>Metastasis</subject><subject>Oncology</subject><subject>Patients</subject><subject>Proteins</subject><subject>Statistical analysis</subject><subject>Survival analysis</subject><subject>Therapeutics</subject><subject>Thermal cycling</subject><subject>Treatment resistance</subject><subject>Vitamin B</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkctv1DAQxiMEolXpjTOyxIUDW8Z2Hs4JoajbIq1UVPE4WhNn0nWVtYPtVHDhb2-yW6rCaUaa33zz-LLsNYezqirqD2YKNMWzkoMUz7JjwUu1Ulzlz5_kR9lpjLcAwKESUMHL7Eiqmhd1WRxnf85_jYFitN4x37O0Jbb2AyZi12RoTD6wL8Ensi6y9dXmmjN03T4TzDrW-BBoxpf2HzZtWTNYZ40fMW394G-swYF9x2CxHSguEy4wpmANa9AZCq-yFz0OkU4f4kn2bX3-tblcba4uPjefNisjAdJK5B0oNAhdrsC0JAoSouuRo8xzEFB2QmHZgipRFpAXfWGQShRlAV1b1yhPso8H3XFqd9QZcingoMdgdxh-a49W_1txdqtv_J3mnNd5IctZ4d2DQvA_J4pJ72w0NAzoyE9Ry-W5IEShZvTtf-itn4Kb71soqaoc9tT7A2WCjzFQ_7gNB72Yqw_m6r25M_7m6QWP8F8r5T2tSaG2</recordid><startdate>20240524</startdate><enddate>20240524</enddate><creator>Anitha, S</creator><creator>Ramasamy, Raveendran</creator><creator>Nachiappa Ganesh, Rajesh</creator><creator>Dubashi, Biswajit</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240524</creationdate><title>Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer</title><author>Anitha, S ; Ramasamy, Raveendran ; Nachiappa Ganesh, Rajesh ; Dubashi, Biswajit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-24d08aca0d480cbe25e22dfa1a3440206d28a6b086a35045f5cae6a2650db99a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Dehydrogenases</topic><topic>Demographics</topic><topic>Gastric cancer</topic><topic>Genetics</topic><topic>Metastasis</topic><topic>Oncology</topic><topic>Patients</topic><topic>Proteins</topic><topic>Statistical analysis</topic><topic>Survival analysis</topic><topic>Therapeutics</topic><topic>Thermal cycling</topic><topic>Treatment resistance</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anitha, S</creatorcontrib><creatorcontrib>Ramasamy, Raveendran</creatorcontrib><creatorcontrib>Nachiappa Ganesh, Rajesh</creatorcontrib><creatorcontrib>Dubashi, Biswajit</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Publicly Available Content database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anitha, S</au><au>Ramasamy, Raveendran</au><au>Nachiappa Ganesh, Rajesh</au><au>Dubashi, Biswajit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-05-24</date><risdate>2024</risdate><volume>16</volume><issue>5</issue><spage>e61032</spage><pages>e61032-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, owing to its aggressive nature and poor prognosis. The role of folate receptors, particularly folate receptor 1 (FOLR1) and folate receptor 2 (FOLR2), in cancer has been increasingly recognized due to their overexpression in various malignancies including gastric cancer, and its potential implications in cancer progression, treatment resistance and as therapeutic targets. To evaluate the expression patterns of FOLR1 and FOLR2 in GC patients' tissue and blood specimens and to correlate these patterns with clinicopathological variables. A total of 58 gastric cancer patients were enrolled at the Regional Cancer Centre (RCC) from March 2017 to March 2020. Immunohistochemical analysis was performed to examine the expression of FOLR1 and FOLR2 in formalin-fixed paraffin-embedded (FFPE) tissue samples. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to analyze FOLR1 and FOLR2 expression in blood samples. Statistical analyses were conducted using chi-square tests, independent T-tests, and Kaplan-Meier survival analysis. FOLR1 and FOLR2 were overexpressed in 82.76% and 70.69% of gastric cancer tissues, respectively. High expression levels of FOLR1 were significantly associated with the diffuse type of gastric cancer (p&lt;0.005). qRT-PCR showed significant overexpression of FOLR1 in gastric cancer blood samples compared to control samples, with a median fold change of approximately 14.18 times. Conversely, FOLR2 was significantly underexpressed in gastric cancer samples, with a fold change of 0.30. However, no significant correlation was found between FOLR2 expression and the clinicopathological features. The overall survival analysis did not show a significant difference in survival rates based on the expression levels of FOLR1 and FOLR2. This study highlights the differential expression patterns of FOLR1 and FOLR2 in gastric cancer and underscores the complexity of their roles in cancer biology. While FOLR1 shows potential as a biomarker for gastric cancer due to its overexpression, further studies are needed to fully elucidate the therapeutic and prognostic implications of folate receptors in gastric cancer.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38915965</pmid><doi>10.7759/cureus.61032</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2024-05, Vol.16 (5), p.e61032
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11194536
source Open Access: PubMed Central; ProQuest Publicly Available Content database
subjects Antibodies
Antigens
Cancer
Chemotherapy
Dehydrogenases
Demographics
Gastric cancer
Genetics
Metastasis
Oncology
Patients
Proteins
Statistical analysis
Survival analysis
Therapeutics
Thermal cycling
Treatment resistance
Vitamin B
title Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A26%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20the%20Folate%20Receptor%20Proteins%20FOLR1%20and%20FOLR2%20in%20Correlation%20With%20Clinicopathological%20Variables%20of%20Gastric%20Cancer&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Anitha,%20S&rft.date=2024-05-24&rft.volume=16&rft.issue=5&rft.spage=e61032&rft.pages=e61032-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.61032&rft_dat=%3Cproquest_pubme%3E3073874058%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c300t-24d08aca0d480cbe25e22dfa1a3440206d28a6b086a35045f5cae6a2650db99a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3073874058&rft_id=info:pmid/38915965&rfr_iscdi=true